Home › Compare › Cagrilintide vs Survodutide
Cagrilintide vs Survodutide
Cagrilintide and Survodutide are both metabolic / weight loss peptides, which is why they get recommended interchangeably — but they are different compounds with different origins. The table below sets out the differences. We give no dosing guidance.
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
CagrilintideMetabolic / Weight Loss
SurvodutideMetabolic / Weight LossAt a glance
| Cagrilintide | Survodutide | |
|---|---|---|
| Category | Metabolic / Weight Loss | Metabolic / Weight Loss |
| Typical route | SubQ | SubQ |
| Shelf life once mixed | ~30 days | ~30 days |
| Commonly reported effects | Appetite suppression Fullness Fat loss (esp. with GLP-1) | Fat loss Increased metabolic rate Appetite suppression |
| Reported considerations | Nausea Injection site reaction | Nausea GI distress |
The differences that actually matter
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Where they overlap: appetite suppression, fat loss (esp. with glp-1).
Reported mainly for Cagrilintide: fullness.
Reported mainly for Survodutide: increased metabolic rate.
What Cagrilintide is
Cagrilintide is a synthetic, long-acting analog of the naturally occurring hormone amylin, which is co-secreted with insulin from pancreatic beta cells. It primarily functions by activating amylin receptors, which are complexes of the calcitonin receptor with receptor activity-modifying proteins (RAMPs 1, 2, or 3), found in various tissues, including the brain. Through this mechanism, cagrilintide influences satiety centers in the hypothalamus and slows the rate of gastric emptying, thereby reducing post-meal gluco
What Survodutide is
Survodutide is a peptide designed to function as a dual agonist for both the glucagon-like peptide-1 (GLP-1) and glucagon receptors. By activating GLP-1 receptors, it is understood to reduce appetite, slow gastric emptying, and enhance glucose-dependent insulin secretion, contributing to improved blood sugar regulation and feelings of fullness. Concurrently, its action on glucagon receptors is intended to increase energy expenditure and stimulate lipolysis, which is the breakdown of stored fats. This combined agoni
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — Cagrilintide and Survodutide are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between Cagrilintide and Survodutide?
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Can you log Cagrilintide and Survodutide in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, Cagrilintide or Survodutide?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.